Skip to navigation Skip to main content Skip to right column
Argus
•
Aug 12, 2025
AbbVie Inc.: Skyrizi and Rinvoq take center stage; raising 2026 EPS estimate
Summary
AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chi
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Related Reports
Technical Assessment: Bullish in the Intermediate-Term
Analyst Report: Lilly(Eli) & Co
Analyst Report: Chevron Corp.
Market Update: CVX, MNST, LLY, TWLO, TRGP
Aug 11, 2025
•
TRGP, TWLO, CVX, MNST, LLY
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
Aug 10, 2025
•
AAPL, AVGO, TTD, LLY, SWRAF, ZBRA
Analyst Profile
Jasper Hellweg
Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing. Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus’ bespoke research on IPOs.
